These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26083626)

  • 1. Optimization of Drug Delivery by Drug-Eluting Stents.
    Bozsak F; Gonzalez-Rodriguez D; Sternberger Z; Belitz P; Bewley T; Chomaz JM; Barakat AI
    PLoS One; 2015; 10(6):e0130182. PubMed ID: 26083626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall.
    Bozsak F; Chomaz JM; Barakat AI
    Biomech Model Mechanobiol; 2014 Apr; 13(2):327-47. PubMed ID: 24395527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Slow-Release Drug-Eluting Stents for the Prevention of Coronary Restenosis: Recent Progress and Future Prospects.
    Hu T; Yang J; Cui K; Rao Q; Yin T; Tan L; Zhang Y; Li Z; Wang G
    ACS Appl Mater Interfaces; 2015 Jun; 7(22):11695-712. PubMed ID: 26011753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular responses to drug eluting stents: importance of delayed healing.
    Finn AV; Nakazawa G; Joner M; Kolodgie FD; Mont EK; Gold HK; Virmani R
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1500-10. PubMed ID: 17510464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
    Iijima R; Mehilli J; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug eluting stents: developments and current status.
    Khan W; Farah S; Domb AJ
    J Control Release; 2012 Jul; 161(2):703-12. PubMed ID: 22366546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell recovery between comparator polymer-based drug-eluting stents.
    Joner M; Nakazawa G; Finn AV; Quee SC; Coleman L; Acampado E; Wilson PS; Skorija K; Cheng Q; Xu X; Gold HK; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2008 Jul; 52(5):333-42. PubMed ID: 18652940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving smooth muscle cell exposure to drugs from drug-eluting stents at early time points: a variable compression approach.
    O'Connell BM; Cunnane EM; Denny WJ; Carroll GT; Walsh MT
    Biomech Model Mechanobiol; 2014 Aug; 13(4):771-81. PubMed ID: 24101254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries.
    Jabara R; Chronos N; Tondato F; Conway D; Molema W; Park K; Mabin T; King S; Robinson K
    J Invasive Cardiol; 2006 Aug; 18(8):383-90. PubMed ID: 16877788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future prospects of drug eluting stents for restenosis.
    Patel MJ; Patel SS; Patel NS; Patel NM
    Acta Pharm; 2012 Dec; 62(4):473-96. PubMed ID: 23333885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular remodeling after coronary stent implantation.
    Vorpahl M; Virmani R; Ladich E; Finn AV
    Minerva Cardioangiol; 2009 Oct; 57(5):621-8. PubMed ID: 19838152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.